Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

07/08/2026 07:40

    Aug 7 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2026        Jun 30, 2025       Mar 31, 2027  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating     loss 420 mln        loss 358 mln        loss 1.33    
  Recurring     loss 422 mln        loss 366 mln        loss 1.34    
  Net           loss 422 mln        loss 367 mln        loss 1.35    
  EPS          loss 30.23 yen      loss 35.43 yen    loss 102.47 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T